Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

391
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
391
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

542
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
542
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

702
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
702
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

444
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
444
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

113
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
113
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

3.8K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrating the Glycemia Risk Index Into Clinical Practice and Research: A Consensus Report.

Journal of diabetes science and technology·2026
Same author

Impact of Continuous Glucose Monitoring Sourcing on Real-World Adherence and Health Care Costs: A Comparative Analysis by Insurance Type.

Clinical diabetes : a publication of the American Diabetes Association·2025
Same author

Risk of new-onset type 1 diabetes in individuals with celiac disease and thyroid disease-An observational study.

Diabetes, obesity & metabolism·2025
Same author

Improved glycemic outcomes in people with type 2 diabetes using smart blood glucose monitoring integrated with popular digital health therapeutics.

Scientific reports·2025
Same author

Expert Clinical Interpretation of Continuous Glucose Monitor Reports From Individuals Without Diabetes.

Journal of diabetes science and technology·2025
Same author

Patient Perspectives on the Benefits and Challenges of Diabetes and Digital Technology.

Clinical diabetes : a publication of the American Diabetes Association·2024

Related Experiment Video

Updated: Nov 18, 2025

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

9.2K

Practical Strategies to Help Reduce Added Sugars Consumption to Support Glycemic and Weight Management Goals.

Hope Warshaw1, Steven V Edelman2,3

  • 1Hope Warshaw Associates, Asheville, NC.

Clinical Diabetes : a Publication of the American Diabetes Association
|February 8, 2021
PubMed
Summary

Low- and no-calorie sweeteners (LNCS) can help manage weight and improve health by reducing added sugar intake. They are recognized by the American Diabetes Association for their role in diabetes nutrition therapy.

More Related Videos

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

654
Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.1K

Related Experiment Videos

Last Updated: Nov 18, 2025

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

9.2K
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

654
Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.1K

Area of Science:

  • Nutrition Science
  • Endocrinology
  • Public Health

Background:

  • Overconsumption of added sugars contributes to global pandemics of obesity, prediabetes, and type 2 diabetes.
  • Dietary shifts are crucial for managing these widespread metabolic conditions.

Purpose of the Study:

  • To inform healthcare providers about the safety and efficacy of low- and no-calorie sweeteners (LNCS).
  • To summarize research on LNCS's role in glycemic and weight management for individuals with or at risk of diabetes.
  • To provide practical counseling strategies for integrating LNCS into healthy eating patterns.

Main Methods:

  • Review of scientific literature on LNCS safety and metabolic effects.
  • Analysis of research evidence regarding LNCS in diabetes nutrition therapy.
  • Synthesis of practical guidance for healthcare professionals.

Main Results:

  • The American Diabetes Association acknowledges LNCS as a tool to reduce intake of low-nutrient-density calories and carbohydrates.
  • Evidence suggests LNCS can beneficially impact glycemia, weight, and cardiometabolic health.
  • LNCS are considered safe and can be integrated into dietary management plans.

Conclusions:

  • LNCS offer a viable strategy for reducing added sugar intake, supporting weight management, and improving glycemic control in diabetes care.
  • Healthcare providers can confidently counsel patients on the appropriate use of LNCS within a healthy diet.
  • Further research and clinical application of LNCS are encouraged for public health benefits.